10-Q · August 10, 2026
Bakkt delivered a substantial GAAP EPS beat at $1.94 versus $0.07 expected, but the result was heavily supported by a $98.5 million non-cash warrant gain and contrasted with an $11.8 million adjusted EBITDA loss.…
10-Q · Filed November 9, 2026 · Our reading of the company's report
The latest report
The provided 10-Q extract does not contain the current-quarter income statement, balance sheet, cash flow statement, segment results, or quantitative guidance, so current financial metrics cannot be verified from the…
The provided 10-Q extract does not contain the current-quarter income statement, balance sheet, cash flow statement, segment results, or quantitative guidance, so current financial metrics cannot be verified from the filing text supplied. The principal update is a material expansion of counterparty and liquidity risk as Bakkt commits capital to institutional and cross-border trading, including overnight lending. Litigation remains unresolved, with Bakkt seeking approximately $10 million and Roman asserting $19 million in counterclaims, although Bakkt prevailed on judgment on the pleadings.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Management concluded that disclosure controls and procedures were effective at a reasonable assurance level as of September 30, 2026.
The Company won judgment on the pleadings on June 12, 2026, and the counterparty withdrew its appeal notice on August 6, 2026; Bakkt is seeking approximately $10 million plus attorneys’ fees.
The 10-Q reports no changes during the quarter ended September 30, 2026 that materially affected, or were reasonably likely to materially affect, internal control over financial reporting.
The Company says capital committed to institutional trading, cross-border trading, and overnight lending represents a meaningful portion of available cash; a counterparty default could reduce liquidity and impair licensed subsidiaries’ capital requirements.
Roman filed counterclaims seeking $19 million in indemnification and damages, while Bakkt is seeking approximately $10 million plus attorneys’ fees; an unfavorable litigation outcome could materially affect financial condition.
The Company states that the scale and cross-border scope of its institutional trading activities are new to it, increasing execution and risk-management uncertainty.
The provided 10-Q text does not include quantitative revenue, EPS, margin, or cash-flow outlook. No guidance change is disclosed.
Bakkt delivered a substantial GAAP EPS beat at $1.94 versus $0.07 expected, but the result was heavily supported by a $98.5 million non-cash warrant gain and contrasted with an $11.8 million adjusted EBITDA loss.…
Bakkt, Inc. reported a significant decline in Q1 revenue to $243.6 million, down 77.1% from $1.1 billion in Q1 2025, leading to a net loss of $11.7 million compared to a profit of $19.4 million in the prior-year…
Totals from the last full session. Insider and politician figures cover 90 days.
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.
The free pages stop at the last full session. Trader shows every trade as it prints.